| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/16/2003 | CN1410419A Method and composition for treating or preventing bacterial infection |
| 04/16/2003 | CN1410127A TB vaccine heat reversal protein65 and multiepi-position HER-2 Antigen fusion protein recombinat protein vaccine |
| 04/16/2003 | CN1410110A Application of Chinese medicine containing sarcandra for treating side effect of anticancer medicine |
| 04/16/2003 | CN1410098A Chinese patent medicine for treating cancer |
| 04/16/2003 | CN1410097A Chinese patent medicine for treating mastoncus |
| 04/16/2003 | CN1410096A Chinese patent medicine for treating primary lung cancer |
| 04/16/2003 | CN1410095A Chinese patent medicine for treating esophagus cancer |
| 04/16/2003 | CN1410084A Xiaoliufengtong injection liquid for eliminating tumour |
| 04/16/2003 | CN1410079A Curcuma zedoary oil nano capsule freeze dried ampoule powder for injection and its preparation technology |
| 04/16/2003 | CN1410066A Ursolic acid poly lactic acid nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410065A Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410064A Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1410058A Application of difenitriazole in preparation of medicine for treating malignant tumour |
| 04/16/2003 | CN1410056A Preparation method of water soluble anticancer medical microsphere |
| 04/16/2003 | CN1105725C Modulators for functions of FAS/APO1 receptors |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/16/2003 | CN1105567C Medicine for treating leukemia and its preparing process |
| 04/16/2003 | CN1105562C Compound injection for treating cancer and preparing method therefor |
| 04/15/2003 | US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine |
| 04/15/2003 | US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 04/15/2003 | US6548679 Antitumor agents |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548531 Bis-indol-3-yl 3-pyrroline derivatives and paclitaxel |
| 04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548515 Use as anticancer agents |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548498 Substituted indan derivatives |
| 04/15/2003 | US6548496 Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases |
| 04/15/2003 | US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases |
| 04/15/2003 | US6548488 Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548078 Implanting a sustained release device to deliver the corticosteroid to the vitreous of the eye and wherein aqueous corticosteroid concentration is less than vitreous corticosteroid concentration during release |
| 04/15/2003 | US6548075 Mixture containing polyglucans |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | CA2130516C New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/11/2003 | WO2002030872A1 Novel aliphatic compounds, process for their preparation and their usage |
| 04/11/2003 | CA2425923A1 Novel aliphatic compounds, process for their preparation and their usage |
| 04/10/2003 | WO2003029825A2 Method for predicting the sensitivity to chemotherapy |
| 04/10/2003 | WO2003029488A2 A method for the early detection of cancer |
| 04/10/2003 | WO2003029475A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND β2m AND UTILIZATION THEREOF |
| 04/10/2003 | WO2003029459A2 Micro-rna molecules |
| 04/10/2003 | WO2003029451A2 Histone deacetylase 9 |
| 04/10/2003 | WO2003029448A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | WO2003029420A2 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029296A1 Human anti-cd40 antibodies |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029289A2 Fragements of heat shock proteins and their use |
| 04/10/2003 | WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003029269A1 Solvent extraction process |
| 04/10/2003 | WO2003029268A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 04/10/2003 | WO2003029248A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029223A1 Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer |
| 04/10/2003 | WO2003029218A1 Novel nitrogenous compound and use thereof |
| 04/10/2003 | WO2003029209A2 Chemical compounds |
| 04/10/2003 | WO2003029201A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | WO2003029198A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 04/10/2003 | WO2003029176A1 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028840A2 Combined compositions and methods for tumor vasculature coagulation and treatment |
| 04/10/2003 | WO2003028809A1 Methods of therapy for b-cell malignancies |
| 04/10/2003 | WO2003028764A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 04/10/2003 | WO2003028761A1 Antitumor agent |
| 04/10/2003 | WO2003028758A1 Novel method of inducing antigen-specific t cells |
| 04/10/2003 | WO2003028757A1 Novel method of inducing antigen-specific t cells |
| 04/10/2003 | WO2003028749A1 Matrix metalloprotease inhibitor |
| 04/10/2003 | WO2003028748A1 A method of extracting deoxyadenosins components from cordyceps sinensis |
| 04/10/2003 | WO2003028736A2 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised |
| 04/10/2003 | WO2003028724A1 Chk1 kinase inhibitors |
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028715A2 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |
| 04/10/2003 | WO2003028713A2 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028711A2 Use of c-kit inhibitors for the treatment of myeloma |
| 04/10/2003 | WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/10/2003 | WO2003028701A2 Liposomes containing (ether)lysolecithins |
| 04/10/2003 | WO2003028697A2 Liposome loading with metal ions |